Robotics is About People – Why You Need Change Management

In 2020, Swiss-based Roche, one of the world’s largest healthcare and pharmaceutical companies, undertook a significant robotic process automation (RPA) implementation for their Asia division. Despite substantial investment and meticulous planning, they encountered a major and unexpected obstacle: People. Roche noted that the “human side of change remains the most challenging element in managing any […]
Digital Transformation is a Human Journey, Not a Technical One

Last week, I sat across from Sarah, the CEO of a $200 million manufacturing company, as she described their recent digital transformation management challenge. Her company had successfully implemented a state-of-the-art ERP system just eighteen months ago, transforming their operations from manual spreadsheets to automated workflows. The initial implementation had been a success story – […]
How Pharma Companies Are Navigating the New Clinical Trial Landscape: A Mixed Response

In the wake of recent regulatory changes regarding diversity in clinical trials, pharmaceutical companies have begun revealing their strategic positions. After previously exploring the various paths companies could take – from maintaining comprehensive diversity programs to reverting to traditional trial methods – we now see how these organizations are actually responding. Their decisions reflect the […]
Don’t Panic, Pivot – Converting Uncertainty into Opportunity

“The goal is to be prepared without being paralyzed by over-planning,” says alliantConsulting managing director Joy Taylor. “Certainty is a CFO’s best friend. Certainty can be accurately modeled, planned for and strategized against,” says Joy Taylor, managing director of Houston-based alliantConsulting. Moments of disruption and uncertainty, of course, are another matter. The contentious international trade […]
How To Plan In Tumultuous Times

“The goal is to be prepared without being paralyzed by over-planning,” says alliantConsulting managing director Joy Taylor. “Certainty is a CFO’s best friend. Certainty can be accurately modeled, planned for and strategized against,” says Joy Taylor, managing director of Houston-based alliantConsulting. Moments of disruption and uncertainty, of course, are another matter. The contentious international […]
The First 72 Hours – The difference between a company survives or folds during a chapter 11 bankruptcy

The call usually comes late on a Friday afternoon. There’s a tremor in the CEO’s voice as they explain their company’s situation – cash is running low, creditors are calling, and employees are starting to whisper about job security. As a bankruptcy and turnaround consultant, these are the moments that define our profession. We’re not […]
Truth Talk – The 5 Reasons 70% of M&A Deals Fail

I have built a career telling hard truths to CEOs. I tell them the things they may not want to hear but need to. When a leader is working through an M&A deal, one of the first truths I bring up is this sobering fact – 70% of M&A deals fail. Let that sink in. […]
eCTD 4.0 Readiness: A Strategic Roadmap for Pharmaceutical Organizations

The electronic Common Technical Document (eCTD) serves as the standardized format for submitting drug applications to regulatory authorities worldwide, streamlining how pharmaceutical companies present their data for review. As the industry prepares to transition to eCTD 4.0 – the next evolution of this digital submission standard – organizations face a critical strategic decision: adapt early […]
Breaking Barriers or Building Bias? The Controversial Debate on Diversity in Clinical Trials

In January 2025, the FDA quietly removed its draft guidance on diversity inclusion in clinical trials from its website, marking a significant shift in the regulatory landscape. This guidance, originally published in June 2024, outlined recommendations for pharmaceutical companies to enhance enrollment of underrepresented racial and ethnic populations in clinical trials. The document served as […]
How Business Owners Are Bracing Themselves for Trump’s Trade War

Tariffs are no longer a threat but a reality. Some business owners are stocking up on supplies to protect their bottom lines. President Trump’s trade war is a sequel that not many company owners have willingly signed up for, but has managed to find a captive audience nonetheless. Much of that audience is American entrepreneurs, […]